Previous PostMedincell’s Partner Teva presented New Data Providing Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) from Invega Sustenna® (paliperidone palmitate)
Next Post[Replay] Videoconference: Company's Latest News, Outlook, and R&D Activities